These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36518546)

  • 1. A comparison of different methods for the first-in-pediatric dose selection.
    Mahmood I
    J Clin Transl Res; 2022 Oct; 8(5):369-381. PubMed ID: 36518546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Simple Method for the Prediction of Therapeutic Proteins (Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins) for First-in-Pediatric Dose Selection: Application of Salisbury Rule.
    Mahmood I
    Antibodies (Basel); 2022 Oct; 11(4):. PubMed ID: 36278619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.
    Mahmood I; Tegenge MA
    J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
    Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mahmood I; Ahmad T; Mansoor N; Sharib SM
    J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
    Edginton AN; Shah B; Sevestre M; Momper JD
    Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model.
    Rashid M; Sarfraz M; Arafat M; Hussain A; Abbas N; Sadiq MW; Rasool MF; Bukhari NI
    BMC Pharmacol Toxicol; 2020 Jul; 21(1):56. PubMed ID: 32727574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of Pediatric Clinical Trials for Coagulation Factors: Application of Pharmacokinetics and Allometry to First-in-Pediatric Dose Selection.
    Mahmood I
    J Clin Pharmacol; 2019 Jun; 59(6):829-834. PubMed ID: 30624769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.
    Mahmood I
    Ther Drug Monit; 2007 Jun; 29(3):271-8. PubMed ID: 17529882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates.
    Kovar L; Schräpel C; Selzer D; Kohl Y; Bals R; Schwab M; Lehr T
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32585880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on the Use of Allometric and Other Scaling Methods to Scale Drug Clearance in Children: Towards Decision Tables.
    van Rongen A; Krekels EH; Calvier EA; de Wildt SN; Vermeulen A; Knibbe CA
    Expert Opin Drug Metab Toxicol; 2022 Feb; 18(2):99-113. PubMed ID: 35018879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spreadsheet-Based Minimal Physiological Models for the Prediction of Clearance of Therapeutic Proteins in Pediatric Patients.
    Mahmood I; Tegenge MA
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S108-S116. PubMed ID: 34185903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Predictive Value of Glomerular Filtration Rate-Based Scaling of Pediatric Clearance and Doses for Drugs Eliminated by Glomerular Filtration with Varying Protein-Binding Properties.
    Cristea S; Krekels EHJ; Allegaert K; Knibbe CAJ
    Clin Pharmacokinet; 2020 Oct; 59(10):1291-1301. PubMed ID: 32314184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling.
    Mahmood I
    Antibodies (Basel); 2020 Aug; 9(3):. PubMed ID: 32764408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
    Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
    Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GFR-Based Method to Predict the Effect of Renal Impairment on the Exposure or Clearance of Renally Excreted Drugs: A Comparative Study Between a Simple GFR Method and a Physiologically Based Pharmacokinetic Model.
    Mahmood I
    Drugs R D; 2020 Dec; 20(4):377-387. PubMed ID: 33150526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization.
    Zhang Y; Zhao S; Wang C; Zhou P; Zhai S
    Front Pharmacol; 2021; 12():636097. PubMed ID: 33815119
    [No Abstract]   [Full Text] [Related]  

  • 20. Physiologically Based Pharmacokinetic Modeling and Allometric Scaling in Pediatric Drug Development: Where Do We Draw the Line?
    Johnson TN; Ke AB
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S83-S93. PubMed ID: 34185901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.